Exhibit 10.3 CONFIDENTIAL Supply AgreementSupply Agreement • December 14th, 2010 • Vantage Health • Pharmaceutical preparations
NANO MOBILE HEALTHCARE, INC. SUBSCRIPTION AGREEMENT NOTICE TO INVESTORSSubscription Agreement • January 2nd, 2024 • Nano Mobile Healthcare, Inc. • Measuring & controlling devices, nec • Delaware
THIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK. THIS INVESTMENT IS SUITABLE ONLY FOR PERSONS WHO CAN BEAR THE ECONOMIC RISK FOR AN INDEFINITE PERIOD OF TIME AND WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. FURTHERMORE, INVESTORS MUST UNDERSTAND THAT SUCH INVESTMENT IS ILLIQUID AND IS EXPECTED TO CONTINUE TO BE ILLIQUID FOR AN INDEFINITE PERIOD OF TIME. NO PUBLIC MARKET EXISTS FOR THE SECURITIES.
STOCK PURCHASE WARRANTVantage Health • January 3rd, 2014 • Pharmaceutical preparations • New York
THIS CERTIFIES THAT, for value received, Accent Healthcare Advisors, LLC, a California limited liability corporation, or its registered assigns, is entitled to purchase from Vantage Health Inc, a Nevada corporation (the “Company”), at any time or from time to time during the period specified in Paragraph 2 hereof, 25,000,000 fully paid and non assessable shares of the Company’s Common Stock, par value $.01 per share (the “Common Stock”), at an exercise price per share equal to $.049 (the “Exercise Price”). The term “Warrant Shares,” as used herein, refers to the shares of Common Stock purchasable hereunder. The Warrant Shares and the Exercise Price are subject to adjustment as provided in Paragraph 4 hereof. The term “Warrants” means this Warrant, by and among the Company and the Entity listed on the execution page thereof. This Warrant is subject to the following terms, provisions, and conditions:
EXCHANGE AGREEMENTExchange Agreement • August 25th, 2015 • Vantage mHealthcare, Inc. • Pharmaceutical preparations • Delaware
This Exchange Agreement is dated and effective as of August 25, 2015 (this “Agreement”) and is entered into by and between Vantage mHealthcare, Inc., a Delaware corporation (the “Company”), on the one hand, and Nanobeak, LLC, a limited liability company organized under the laws of Delaware (the “Stockholder”), on the other hand.
INDEMNIFICATION AGREEMENTIndemnification Agreement • December 19th, 2013 • Vantage Health • Pharmaceutical preparations • Nevada
This Indemnification Agreement (this “Agreement”) is dated as of 16 December 2013, and is between Vantage Health, Inc., a Nevada corporation (the “Company”), and William S. Rees, Jr. (“Indemnitee”).
Termination AgreementTermination Agreement • May 2nd, 2012 • Vantage Health • Pharmaceutical preparations
Exhibit 10.4 Consulting Retainer Agreement ==================================== ============================================ This Agreement is made effective as of 11 APRIL 2010, by and between MOXISIGN PTY LTD and Salim Essa of 39 First Avenue,...Vantage Health • December 14th, 2010 • Pharmaceutical preparations
Supply AgreementVantage Health • October 20th, 2010 • Pharmaceutical preparations
GLOBAL SETTLEMENT AGREEMENT& MUTUAL RELEASE OF ALL CLAIMS BY ALL PARTIESGlobal Settlement Agreement • May 5th, 2017 • Nano Mobile Healthcare, Inc. • Measuring & controlling devices, nec • Nevada
THIS GLOBAL SETTLEMENT AGREEMENT & MUTUAL RELEASE OF ALL CLAIMS BY ALL PARTIES (“Agreement”) is dated, entered into and made fully effective (irrespective of the date actually signed by the parties) as of the 10th day of March, 2017, by and among JDF Capital, Inc., a New York Corporation, (“Plaintiff”), and NANO MOBILE HEALTHCARE, INC., a Delaware corporation, f/k/a Vantage mHealthcare, Inc., f/k/a Vantage Health, Inc., a Nevada Corporation; (together, “Defendants” or “NANO”).
AGREEMENT OF CONVEYANCE, TRANSFER AND ASSIGNMENT OF SUBSIDIARY AND ASSUMPTION OF OBLIGATIONSAgreement • October 10th, 2013 • Vantage Health • Pharmaceutical preparations
This Agreement of Conveyance, Transfer and Assignment of Subsidiary and Assumption of Obligations (“Transfer and Assumption Agreement”) is made as of September __, 2013, by Vantage Health, a Nevada corporation (“Assignor”), Lisa Ramakrishnan (“Assignee”), and Moxisign (PTY) Ltd., a South African corporation (“Subsidiary”).
Exhibit 10.4 Consulting Retainer Agreement ==================================== ============================================ This Agreement is made effective as of 11 APRIL 2010, by and between MOXISIGN PTY LTD And Salim Essa of 39 First Avenue,...Vantage Health • October 20th, 2010 • Pharmaceutical preparations
Addendum to Termination Agreement IT IS THEREFORE AGREED AS FOLLOWS:Vantage Health • May 24th, 2012 • Pharmaceutical preparations
SUBLICENSE AGREEMENTSublicense Agreement • February 20th, 2014 • Vantage Health • Pharmaceutical preparations
This Sublicense Agreement (“Agreement”), effective as of the date of last signature below (the “Effective Date”), is by and between Nanobeak, Inc. a California corporation having its principal place of business at 575 Madison Avenue, 10th Floor, New York, NY 10022 (“Nanobeak”) and Vantage Health, a Nevada corporation, with a place of business at 401 Warren Street, Suite 200, Redwood City, CA 94063 (“VNTH”).
KINERET KALLMANNano Mobile Healthcare, Inc. • May 5th, 2017 • Measuring & controlling devices, nec
Kineret Kallman (the “Owner”) is the owner of certain notes (the “Notes”) of Nano Mobile Healthcare Inc. (the “Company”) and Owner may have certain claims against the Company relating to the Notes. For good and valuable consideration, the receipt of which is hereby acknowledged by the Company, the Company and Owner agree as follows:
SETTLEMENT AGREEMENTSettlement Agreement • May 5th, 2017 • Nano Mobile Healthcare, Inc. • Measuring & controlling devices, nec • New Jersey
THIS SETTLEMENT AGREEMENT (the “Agreement”) is made and entered into on this 24th day of April, 2017, by and among Navesink River Capital, LLC (hereinafter Navesink), and Adam 2, L.L.C. (hereinafter “Adam”), collectively referred to as the “Owners,” who are the owners of certain notes (the “Notes”) of Phoenix Worldwide Holdings, Inc. (“Phoenix”); Phoenix, and Nano Mobile Healthcare, Inc. f/k/a Vantage mHealthcare Inc., with its principal office at 3 Columbus Circle, 15th Floor, New York, NY 10019 (hereinafter referred to as “NANO”).
Vantage Health, Inc. DIRECTOR RETAINER AGREEMENTVantage Health • December 19th, 2013 • Vantage Health • Pharmaceutical preparations • Nevada
THIS RETAINER AGREEMENT (this “Agreement”) is entered into by and between Vantage Health, Inc., a Nevada corporation (the “Company”), and William S. Rees, Jr. (“Director”) as of 16 December 2013.
EMPLOYMENT SERVICES AGREEMENTEmployment Services Agreement • February 14th, 2012 • Vantage Health • Pharmaceutical preparations • Nevada
THIS AGREEMENT (“Agreement” or “Contract”) is between Peninsula Holdings Ltd, having its principal place of business in Victoria, Mahe, Seychelles ("Peninsula"); and Vantage Health, a publicly quoted Nevada Corporation having its principal place of business in Los Angeles, California, and Cape Town, South Africa ("Vantage").
LICENSE AGREEMENT NATIONAL AERONAUTICS AND SPACE ADMINISTRATION AND NANOBEAK INC. (PARTIALLY) EXCLUSIVE LICENSE AGREEMENT No. DE- LICENSE COMMENCEMENT DATE: 12/31/13License Agreement • February 19th, 2014 • Vantage Health • Pharmaceutical preparations
This License Agreement (“AGREEMENT”) is entered into between the National Aeronautics and Space Administration (NASA), an agency of the United States, hereinafter referred to as LICENSOR, having its headquarters in Washington, D.C., and Nanobeak Inc., a corporation of the State of California, having its principal place of business at 401 Warren Street, Suite 200, Redwood City, CA 94063, hereinafter referred to as LICENSEE, as of the date of execution of the last PARTY hereto.
SETTLEMENT AGREEMENTSettlement Agreement • October 15th, 2021 • Nano Mobile Healthcare, Inc. • Measuring & controlling devices, nec • New York
THIS SETTLEMENT AGREEMENT (the “Agreement”) is made and entered into as of October 6, 2021, by and among VIS VIRES GROUP, INC. (“VVG”), a corporation formed and existing pursuant to the laws of the State of New York and having a principal place of business located at 111 Great Neck Road, Suite 216, Great Neck, New York 11021 and NANO MOBILE HEALTHCARE, INC. f/k/a VANTAGE HEALTHCARE, INC. (“Nano”), a corporation formed and existing pursuant to the laws of the State of Delaware and having a principal place of business located at One Boston Place, Suite 2600, Boston, MA 02108, collectively referred to herein as the “Settling Parties.”
